Rastreamento de câncer cervical

Última revisão: 6 Nov 2022
Última atualização: 14 Jun 2022

Resumo

Detalhes

  • Técnicas de amostragem cervical
  • Citologia cervical
  • teste de vírus do papiloma humano (HPV)
  • Vacinação contra o papilomavírus humano (HPV)
  • Colposcopia
  • Rastreamento
Detalhes completos

Colaboradores

Autores

Richard T. Penson, MD, MRCP
Richard T. Penson

Clinical Director

Medical Gynecologic Oncology

Division of Hematology Oncology

Massachusetts General Hospital

Boston

MA

Declarações

RTP has received institutional research funding from Array BioPharma Inc., AstraZeneca, Genentech, and Vascular Biogenics Ltd. RTP has been paid for participating in scientific advisory boards for: AbbVie, AstraZeneca, Clovis Oncology, Curio Science, Eisai Inc., Genentech, Janssen Oncology (J&J), Merck & Co., Mersana Therapeutics, Inc., NewLink Genetics, Nexus Global Group, Pieris Pharma Inc, Roche, Inc., Sutro Biopharma, Syndax Pharmaceuticals, Tesaro Inc., and Vascular Biogenics Ltd.

Marcela G. del Carmen, MD, MPH
Marcela G. del Carmen

Chief Medical Officer

Massachusetts General Physicians Organization

Division of Gynecologic-Oncology

Massachusetts General Hospital

Professor

Department of Obstetrics, Gynecology and Reproductive Biology

Harvard Medical School

Boston

MA

Declarações

MDC declares that she has no competing interests.

Revisores

Deirdre Lyons, MB, BCh, BAO, MRCOG

Consultant in Obstetrics & Gynaecology

Lead Clinician in Colposcopy

Imperial College Healthcare NHS Trust

London

UK

Declarações

DL declares that she has no competing interests.

Matejka Rebolj, PhD

Scientific Researcher

Centre for Epidemiology and Screening

Institute of Public Health

University of Copenhagen

Copenhagen

Denmark

Declarações

MR declares that she has no competing interests.

Shagufta Yasmeen, MD

Associate Professor

Department of Obstetrics and Gynecology

UC Davis Health System

Sacramento

CA

Declarações

SY declares that she has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal